TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.

Philip W Kantoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.